WednesdaySep 14, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Strengthens Board of Directors to Boost Efforts toward Regulatory Approval of Potential Treatment for Hypertension

Lexaria Bioscience is a global innovator in drug delivery platforms whose lead technology, DehydraTECH, has been shown to increase the bioavailability of APIs The company recently announced that Catherine Turkel, PharmD, Ph.D., has joined its board of directors Dr. Turkel, who brings over 20 years’ experience, has previously formulated Food and Drug Administration (“FDA”) registration and commercial strategic plans, as well as led global development programs for pharmaceutical and biologic treatments Dr. Turkel will lend her drug registration experience and regulatory expertise to Lexaria at a time when the company is journeying toward regulatory approval for DehydraTECH-CBD, its drug candidate…

Continue Reading

WednesdaySep 14, 2022 4:20 am

420 with CNW — Study Says Pharma Industry Loses Billions as Cannabis Legalization Spreads

Over the past two or so decades, a growing body of scientific research has proved that cannabis has the potential to treat a variety of medical conditions. Even though federal law classifies cannabis as a Schedule I controlled substance with no medical applications, studies have found that the drug can be effective against inflammation, anxiety disorders, chronic pain and high blood pressure, among other things. As people become more cognizant of the short- and long-term side effects of using pharmaceutical medications, “safer” alternatives such as cannabis have grown increasingly popular. Dozens of states now allow their residents to purchase and…

Continue Reading

TuesdaySep 13, 2022 4:20 pm

420 with CNW — California Governor Enacts Laws Providing Marijuana Use Protections to Patients

With more than 30 states legalizing the use of cannabis for medical purposes, America is home to one of the largest medical cannabis industries in the world. Despite being criminalized for decades and classified as a Schedule I drug with no medical applications, cannabis has proven to be effective at mitigating a wide variety of medical conditions. However, the fact that federal law still outlaws medical cannabis means that patients who use the plant for medical purposes as per state law are often at risk of discrimination. In a bid to prevent this from happening, California Governor Gavin Newsom recently…

Continue Reading

TuesdaySep 13, 2022 12:00 pm

REZYFi, Inc. Leverages Corporate Strengths to Impact Real Estate and Lending Industries Through Wholly Owned Subsidiaries REZYFi Lending and ResMac Inc.

While traditional lenders remain reluctant to serve state-licensed cannabis industry prospects, REZYFi focuses on servicing the sector ResMac subsidiary expects to accumulate $285 million in retail origination and $250 million in wholesale origination in 2023 The National Association of Realtors(R) reported one-third of surveyed agents experienced an increase in demand for warehouses, 28% in land demand, and 23% in demand for storefront property REZYFi, a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses, is one of the first mortgage bankers of its kind in the United States, leveraging its position in a market where…

Continue Reading

TuesdaySep 13, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC), Cannabis Brand Builder, is Ramping Up its HR Productivity and Effectiveness One Appointment at a Time

A 2017 study by McKinsey & Company showed that high performers tend to be 400% more productive than average ones.  This outlook has shaped Flora Growth’s hiring strategy for 2022, with the appointment of several key individuals whose proven talents and productivity are seen as critical to the company’s goal of delivering the most compelling customer experiences, most recently with the appointment of Elshad Garayev as Flora’s Chief Financial Officer (“CFO”) Mr. Garayev’s appointment marks the latest addition to a growing list of leaders ready to elevate the company to another level of international performance In a study conducted in…

Continue Reading

TuesdaySep 13, 2022 4:20 am

420 with CNW — Four Novel Ways in Which Hemp Can Be Used Today

Hemp, or industrial hemp as it is commonly known, has numerous uses in today’s world. The plant, which is a member of the cannabaceae family, contains cannabidiol (CBD). CBD is one of the two primary compounds found in the cannabis plant, the other being THC. Unlike THC, however, the compound doesn’t induce any highs when ingested. Instead, CBD possesses properties that can be harnessed to treat inflammation, insomnia and anxiety. This compound usually works by activating some receptors in the human brain responsible for the regulation of the central nervous system. Research has also found that CBD may be useful…

Continue Reading

MondaySep 12, 2022 4:20 pm

420 with CNW — Pennsylvania Announces Program to Pardon Minor Cannabis Offenses

Decades of cannabis policing have significantly impacted society, especially among Black and Brown communities that were much more likely to be arrested and incarcerated for cannabis offenses despite similar use rates to White people. More than two decades after states first started legalizing cannabis, tens of thousands of people are still affected by cannabis convictions, either languishing in jail or failing to integrate into society due to their criminal records. For most cannabis reform activists, efforts to legalize the drug have had a major focus on social and criminal justice to help alleviate the damage done by the decades-long war…

Continue Reading

MondaySep 12, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Acquires 27th Worldwide Patent Applying to a Range of APIs in Ready-to-Drink Consumer Retail Beverage Products

Lexaria’s Mexican patent “Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Ingredients” joins the ranks of previously issued patents in Australia, India, Japan and the EU The patent allows the company to provide value in gaining regulatory approval for its DehydraTECH(TM)-enabled CBD for multiple indications in the health and wellness field Additional claims to Mexican patent #390001 include Alzheimer’s disease, Parkinson’s disease, schizophrenia, Human Immunodeficiency Virus (“HIV”) dementia, obesity, hepatic diseases, diabetes, appetite disorders, cancer chemotherapy, benign prostatic hypertrophy, irritable bowel syndrome, biliary diseases, ovarian disorders, marijuana abuse, and alcohol, opioid, nicotine, or cocaine addictions The global market of CBD for…

Continue Reading

MondaySep 12, 2022 4:20 am

420 with CNW — New Study Debunks ‘Lazy Stoner’ Stereotype of Marijuana Users

After decades of cannabis criminalization and anti-cannabis propaganda, certain stereotypes about cannabis users have become entrenched in the public mind. The stereotypical image of a cannabis user as an apathetic “lazy stoner” who spends his days getting high, polishing off Doritos and generally contributing nothing to society is one example. Tons of people, especially older generations that grew up in the era of the drug war, tend to believe this stereotype. However, a new study has revealed that the stereotype of cannabis users as unmotivated and lazy is far from factual. Researchers found that there was no difference in reward-based…

Continue Reading

FridaySep 09, 2022 4:20 pm

420 with CNW — Director of Federal Health Agency Blasts Cannabis Research Barriers Impeding Opioid Research

Decades of cannabis prohibition in America have made scientific research into cannabis virtually impossible. Even as dozens of states have now legalized cannabis for medical use, federal law has proven to be a major challenge to cannabis researchers. Several studies have shown that the drug does in fact have effective medical applications, but federal prohibition still remains a hindrance to cannabis research. According to a top federal health official, the nascent marijuana research space is “fraught with hurdles” that have to be addressed in order to facilitate studies into how cannabinoids can be used as safer tools to manage pain…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000